Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Watching Expion360; Zacks Small-Cap Research Sets $4.25 Price Valuation

Watching Expion360; Zacks Small-Cap Research Sets $4.25 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01302023_XPON_Lantier.pdf

byHappy Mohamed

January 30, 2023

1 minute read

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01302023_XPON_Lantier.pdf

Analyst Ratings

Where Centessa Pharmaceuticals Stands With Analysts

By Benzinga Insights

August 15, 4:00 PM

Over the past 3 months, 5 analysts have published their opinion on Centessa Pharmaceuticals (NASDAQ:CNTA) stock. These analysts…

CNTA

Keybanc Maintains Overweight on Terex, Lowers Price Target to $44

By Benzinga Newsdesk

July 12, 5:03 AM

Keybanc analyst Todd Thomas maintains Terex (NYSE:TEX) with a Overweight and lowers the price target from $54 to $44.

TEX

3,400 Bitcoin Was Just Transferred From Coinbase To Binance

By Benzinga Insights

July 18, 12:05 PM

What happened: An anonymous Bitcoin (CRYPTO: BTC) whale just transferred $75,626,521 worth of Bitcoin off Coinbase, and the investor then sent these funds to Binance.

BTC

News

Second Launch Attempt For Debut Flight Of NASA’s Artemis Moon Rocket Is Still Possible As Early As Friday, Sept 2, Pending Data Review

By Benzinga Newsdesk

August 29, 1:44 PM

-Reuters

Watching Expion360; Zacks Small-Cap Research Sets $4.25 Price Valuation

Related Posts

Where Centessa Pharmaceuticals Stands With Analysts

Keybanc Maintains Overweight on Terex, Lowers Price Target to $44

3,400 Bitcoin Was Just Transferred From Coinbase To Binance

Second Launch Attempt For Debut Flight Of NASA’s Artemis Moon Rocket Is Still Possible As Early As Friday, Sept 2, Pending Data Review